Tetraisopropyl (4R,4'R,5R,5'R)-[2,2'-bi(1,3,2-dioxaborolane)]-4,4',5,5'-tetracarboxylate

Catalog No. :
ACDGVO511
CAS No. :
230299-10-2
Molecular Formula :
C20H32B2O12
Molecular Weight :
486.09

IUPAC Name:tetraisopropyl (4R,4'R,5R,5'R)-[2,2'-bi(1,3,2-dioxaborolane)]-4,4',5,5'-tetracarboxylate

Tetraisopropyl (4R,4'R,5R,5'R)-[2,2'-bi(1,3,2-dioxaborolane)]-4,4',5,5'-tetracarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameTetraisopropyl (4R,4'R,5R,5'R)-[2,2'-bi(1,3,2-dioxaborolane)]-4,4',5,5'-tetracarboxylate
IUPAC Nametetraisopropyl (4R,4'R,5R,5'R)-[2,2'-bi(1,3,2-dioxaborolane)]-4,4',5,5'-tetracarboxylate
Molecular FormulaC20H32B2O12
Molecular Weight486.09
SMILESCC(C)OC([C@H]1[C@@H](OB(B2O[C@H]([C@@H](O2)C(OC(C)C)=O)C(OC(C)C)=O)O1)C(OC(C)C)=O)=O
InChI KeyGDBJZTBFVNVAPH-KLHDSHLOSA-N
SynonymBIS(DIISOPROPYL-L-TARTRATE GLYCOLATO)DI&;Bis(diisopropyl-L-tartrate glycolato)diboron;2-[4,5-bis[oxo(propan-2-yloxy)methyl]-1,3,2-dioxaborolan-2-yl]-1,3,2-dioxaborolane-4,5-dicarboxylic acid dipropan-2-yl ester;[2,2'-Bi-1,3,2-dioxaborolane]-4,4',5,5'-tetracarboxylic acid, 4,4',5,5'-tetrakis(1-methylethyl) ester, (4R,4'R,5R,5'R)-
CAS No.230299-10-2

Synthetic Route by SureRoute

1. ACDGVO511 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKIQW295 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDGVO511 route product structure diagram
    ACDGVO511230299-10-2
Inquiry

2. ACDGVO511 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKIQW295 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDGVO511 route product structure diagram
    ACDGVO511230299-10-2
Inquiry

Comments (0)